Highlighting our cell and gene therapy sector data, an update on the 2024 clinical pipeline, and gene therapy indications driving higher patient populations.
Highlighting our cell and gene therapy sector data, an update on the 2024 clinical pipeline, and gene therapy indications driving higher patient populations.
